Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 8
1966 1
1967 2
1968 5
1969 6
1970 11
1971 10
1972 31
1973 26
1974 22
1975 20
1976 23
1977 21
1978 27
1979 25
1980 22
1981 25
1982 20
1983 44
1984 34
1985 32
1986 41
1987 61
1988 77
1989 78
1990 119
1991 99
1992 104
1993 138
1994 119
1995 186
1996 150
1997 161
1998 190
1999 181
2000 209
2001 409
2002 291
2003 263
2004 379
2005 374
2006 384
2007 362
2008 418
2009 469
2010 521
2011 578
2012 528
2013 677
2014 870
2015 801
2016 755
2017 737
2018 794
2019 796
2020 939
2021 991
2022 990
2023 994
2024 179

Text availability

Article attribute

Article type

Publication date

Search Results

15,378 results

Results by year

Filters applied: . Clear all
Page 1
Hepatocellular carcinoma.
Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Vogel A, et al. Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6. Lancet. 2022. PMID: 36084663 Review.
Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. ...In this Seminar, we present an update on the causes, diagnosis, molecular classification, and treatment of hepatocellular carcinoma
Hepatocellular carcinoma is one of the most common cancers worldwide and represents a major global health-care challenge. ...I
Hepatocellular carcinoma.
Forner A, Reig M, Bruix J. Forner A, et al. Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5. Lancet. 2018. PMID: 29307467 Free article. Review.
Hepatocellular carcinoma appears frequently in patients with cirrhosis. ...Finally, sorafenib, lenvatinib, which is non-inferior to sorafenib, and regorafenib increase survival and are the standard treatments in advanced hepatocellular carcinoma. This
Hepatocellular carcinoma appears frequently in patients with cirrhosis. ...Finally, sorafenib, lenvatinib, which is non-inferi
Hepatocellular Carcinoma: New Developments.
Ganesan P, Kulik LM. Ganesan P, et al. Clin Liver Dis. 2023 Feb;27(1):85-102. doi: 10.1016/j.cld.2022.08.004. Epub 2022 Oct 18. Clin Liver Dis. 2023. PMID: 36400469 Review.
This is a review of current practices and upcoming developments regarding hepatocellular carcinoma (HCC). This includes a contemporary review of the diagnosis, staging, and treatment of HCC. ...
This is a review of current practices and upcoming developments regarding hepatocellular carcinoma (HCC). This includes a cont …
Management of Hepatocellular Carcinoma: A Review.
Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, Pawlik TM. Brown ZJ, et al. JAMA Surg. 2023 Apr 1;158(4):410-420. doi: 10.1001/jamasurg.2022.7989. JAMA Surg. 2023. PMID: 36790767 Review.
IMPORTANCE: Hepatocellular carcinoma (HCC) is the sixth most common malignancy and fourth leading cause of cancer-related death worldwide. ...
IMPORTANCE: Hepatocellular carcinoma (HCC) is the sixth most common malignancy and fourth leading cause of cancer-related deat …
The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update.
Wen N, Cai Y, Li F, Ye H, Tang W, Song P, Cheng N. Wen N, et al. Biosci Trends. 2022 Mar 11;16(1):20-30. doi: 10.5582/bst.2022.01061. Epub 2022 Feb 24. Biosci Trends. 2022. PMID: 35197399 Free article. Review.
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second leading cause of cancer-related mortality worldwide. ...
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the second leading cause of cancer-related mortality wo
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment.
Piñero F, Dirchwolf M, Pessôa MG. Piñero F, et al. Cells. 2020 Jun 1;9(6):1370. doi: 10.3390/cells9061370. Cells. 2020. PMID: 32492896 Free PMC article. Review.
Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death worldwide. ...
Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death worldwide. ...
Hepatocellular Carcinoma.
Gilles H, Garbutt T, Landrum J. Gilles H, et al. Crit Care Nurs Clin North Am. 2022 Sep;34(3):289-301. doi: 10.1016/j.cnc.2022.04.004. Epub 2022 Jul 20. Crit Care Nurs Clin North Am. 2022. PMID: 36049848 Review.
Hepatocellular carcinoma (HCC) is a primary liver malignancy commonly encountered in the setting of chronic liver disease and cirrhosis. ...
Hepatocellular carcinoma (HCC) is a primary liver malignancy commonly encountered in the setting of chronic liver disease and
Hepatocellular Carcinoma.
Villanueva A. Villanueva A. N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263. N Engl J Med. 2019. PMID: 30970190 Review. No abstract available.
The diagnosis and treatment of hepatocellular carcinoma.
Hartke J, Johnson M, Ghabril M. Hartke J, et al. Semin Diagn Pathol. 2017 Mar;34(2):153-159. doi: 10.1053/j.semdp.2016.12.011. Epub 2016 Dec 20. Semin Diagn Pathol. 2017. PMID: 28108047 Review.
Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is closely related to advanced liver disease. ...In this review, current approaches to management of hepatocellular carcinoma are discussed, which incorporate both
Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is closely related to advanced liver
Epigenetics in hepatocellular carcinoma.
Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Nagaraju GP, et al. Semin Cancer Biol. 2022 Nov;86(Pt 3):622-632. doi: 10.1016/j.semcancer.2021.07.017. Epub 2021 Jul 26. Semin Cancer Biol. 2022. PMID: 34324953 Review.
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and has a high fatality rate. ...
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and has a high fatality rate. ...
15,378 results
You have reached the last available page of results. Please see the User Guide for more information.